All stock lists Unlock the score
Dutch Bros Inc. (New York Stock Exchange:BROS)
US · Delayed Price · Currency is USD
41.81+0.33 (+0.78%)
Market cap
$7.85B
Insider Score
Analyst consensus
Listed since
Sep 15, 2021
Website
Insider Score
/ 100
BROS Insider Score
Dutch Bros Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
BROS analyst forecast
BROS analyst consensus
Moderate Buy13 ratings
Buy 12 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
BROS 12-month price target
$71.15+70.3% upsideaverage of 13 firms
$88.00High
$46.00Low
Best analysts covering BROS
- TD Cowen78%success rate · 9 calls
- JP Morgan71%success rate · 7 calls
- Stifel63%success rate · 8 calls
- Baird40%success rate · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
BROS analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| UBS | — | $75.00 | +80.8% | — | 2026-10-26 | |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-10-23 |
| RBC Capital | Sector Perform | $46.00 | +8.8% | Downgraded | 2026-10-22 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-21 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-10-21 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-10-21 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-10-15 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-10-15 |
| — | Baird | Outperform | — | — | Reiterated | 2026-10-02 |
| Robert W. Baird | — | $60.00 | +55.4% | — | 2026-10-02 | |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-09-30 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-09-29 |
| — | DA Davidson | Buy | — | — | Reiterated | 2026-09-28 |
| — | Melius Research | Buy | — | — | Reiterated | 2026-09-18 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-09-18 |
| Raymond James | — | $59.00 | +46.9% | — | 2026-09-18 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-09-11 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-08-06 |
| — | DA Davidson | Buy | — | — | Reiterated | 2026-08-06 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-06 |
| Telsey Advisory Group | Outperform | $74.00 | +13.1% | Reiterated | 2026-07-31 | |
| Morgan Stanley | Overweight | $88.00 | +37.4% | Reiterated | 2026-07-16 | |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-06-30 |
| Piper Sandler | Neutral | $68.00 | -3.8% | Reiterated | 2026-06-22 | |
| — | DA Davidson | Buy | — | — | Reiterated | 2026-06-22 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-06-10 |
| — | DA Davidson | Buy | — | — | Reiterated | 2026-06-01 |
| — | DA Davidson | Buy | — | — | Reiterated | 2026-05-21 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-05-20 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-07 |
| Piper Sandler | Neutral | $61.00 | +3.3% | Reiterated | 2026-05-07 | |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-07 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-05-07 |
| Oppenheimer | — | $72.00 | +25.2% | — | 2026-05-01 | |
| — | DA Davidson | Buy | — | — | Reiterated | 2026-04-27 |
| Piper Sandler | — | $59.00 | +12.5% | — | 2026-03-09 | |
| Wolfe Research | — | $77.00 | +46.8% | — | 2026-03-09 | |
| Goldman Sachs | Buy | $75.00 | +39.9% | Upgraded | 2026-03-02 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-02-13 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-02-13 |
| RBC Capital | — | $75.00 | +48.6% | — | 2026-02-13 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-01-20 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-07 |
| Bernstein | — | $76.00 | +20.1% | — | 2026-01-07 | |
| Mizuho | Outperform | $80.00 | +30.7% | Reiterated | 2025-12-04 | |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-12-03 |
| — | TD Cowen | Buy | — | — | Reiterated | 2025-12-01 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-11-06 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2025-11-06 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-11-06 |
| Morgan Stanley | — | $84.00 | +56.0% | — | 2025-11-06 | |
| — | Stifel | Buy | — | — | Reiterated | 2025-10-31 |
| Stifel Nicolaus | — | $75.00 | +33.7% | — | 2025-10-31 |
BROS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-12 | 0.10 | 0.17 | $424.8M | $443.6M |
| 2026-05-06 | 0.16 | 0.16 | $449.7M | $464.4M |
| 2026-08-05 | 0.29 | 0.33 | $525.4M | $550.9M |
| 2026-11-04 | 0.24 | 0.00 | $548.4M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.